Programme Information / Privacy and Consent

MAVENCLAD® adveva Patient Support Programme (PSP)

Product PSP information & Privacy Consent – about this programme

This is a patient support programme administered by Merck Healthcare Pty Ltd (“Merck”) and is intended only for patients prescribed MAVENCLAD® – Registered trademark in Australia or New Zealand (ANZ). 

The programme aims to provide support to patients prescribed MAVENCLAD® by way of general advice and reminders to assist with their treatment and monitoring. The specific support available depends on the treatment you have been prescribed and the programme you are enrolled in.

All advice is of a general nature to support the prescribing instructions of your doctor and is never intended to replace advice or instructions provided by your prescribing doctor or healthcare team. You should contact your doctor for specific advice about your treatment or in the case of immediate or urgent advice.

Your treatment details will be shared with your treating Doctor to assist them in managing your care on MAVENCLAD®.

Participation is entirely voluntary, and you can withdraw anytime simply by contacting the programme on the nominated phone number/email.

Privacy, collection of information and consent information you should be aware of

It is strongly recommended that you read and understand Merck’s full privacy statement for this programme. To be enrolled in this support programme we shall require that you acknowledge that you are prescribed the product, that you have read and understood the information about the programme and the privacy/collection statement and that you provide your consent to Merck to be enrolled as a member of the programme. This patient support programme is operated by personnel within Merck’s Medical Services Information department. Depending on your programme specifics, you may be contacted by someone from Merck’s Medical Services Information by phone, mail, email or SMS.

By providing your personal information to Merck and continuing to engage with Merck via this programme you are providing your consent to the personal information you provide being collected, used and stored as described in the full Merck privacy statement (link below).

We only collect information that is required to assess your eligibility and to provide assistance and services within this support programme. This includes (but is not limited to) information such as your name, address, date of birth, past treatments (if any), details of the Merck treatment (e.g. dose, frequency etc) and your prescribing doctors name and clinic address.

In the instance of changes to the programme or product or an adverse event being reported while enrolled in the MAVENCLAD® Patient Support Programme, Merck, or an authorised third party may contact you for follow-up or may contact your doctor to obtain more detailed information in some cases.

The MAVENCLAD® Patient Support Programme will notify your Doctor that they have a patient enrolled in the programme and if requested share your treatment details from the programme with them to assist in the management of your appointments and care on MAVENCLAD®.

Your personal information is only provided/accessible to those that need it to fulfil some aspect of the service which you have consented to such as the mandatory reporting of side effects or other safety issues you advise us of; or programme/system maintenance. This sometimes includes 3rd party service providers who assist Merck with the programme, but only the minimum relevant information needed is provided. All persons with access to your personal information are bound by the Merck privacy statement. 

Anonymised data and information may be used by Merck or its affiliates – this includes any member of the Merck Group to evaluate and improve the programme and may be published in a medical journal. The reports or abstracts will not identify any individual patient or identify anyone from your healthcare team, the data will be anonymised.

All information collected from you is kept on secure, password-controlled servers in Australia and New Zealand (ANZ) and outside of ANZ in countries that have similar privacy laws/regulations and expectations as in ANZ. At all times, adherence to the Australian and New Zealand (ANZ) Privacy Principles will be maintained.

For more details about how Merck handles your personal/sensitive information, the use of “cookies” or Google analytics; please refer to the Merck privacy statement (link below).

You can withdraw your consent or alter your preferences at any time simply by advising us. 

Phone: AUSTRALIA 1800 290 895 NEW ZEALAND 0800 426 252 

Hours: 9.00am to 5.00pm (AEST)


Link to Merck privacy statement:

More information:

If you have any questions or comments, please feel free to contact the Privacy Officer at Merck Healthcare (Australia) via the above contact details.

Merck Healthcare Pty Ltd | ABN 72 006 900 830 | Suite 1, Level 1, Building B, 11 Talavera Road, Macquarie Park, NSW 2113 Australia
Phone: 1800 257 348

Healthcare Logistics, 58 Richard Pearse Drive, Airport Oaks, Auckland 2022
Phone (NZ) 0800 426 252

Date of preparation: July 2021 | AU-NONNI-00009

Date of revision: 30 July 2021